About Daniel Estay
Form D filings for SonoVascular from 2022 to 2023 list Daniel Estay as chief executive officer and director.
Daniel Estay first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Estay in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Estay works with at each company, as listed on that company's latest Form D.
SonoVascular, Inc. · Form D/A, Jan 17, 2023
WS
William Starling
Director